[Traffic]

New traffic signals were added to two The Woodlands intersections in late 2020. (Courtesy Fotolia) Two new traffic signals at intersections in The Woodlands slated for late 2020 operation New traffic signals were added to two The Woodlands intersections in late 2020. (Courtesy Fotolia) New traffic signals were added to two The Woodlands intersections in late 2020. (Courtesy Fotolia) Now is the chance to help your local community succeed. Become a Patron by contributing to Community Impact Newspaper and gain daily insight into what's happening in your own backyard. Thank you for reading and supporting community journalism. Work on installing two new traffic signals in The Woodlands was expected to be completed by December, according to Montgomery County Precinct 3. New additional info Trails Drive and Technology Forest Boulevard This project will add a traffic signal at New Trails Drive and Technology Forest Boulevard. Technology Forest will be widened to accommodate a right turn-only lane and a straight or left-turn lane in each direction at the intersection with New Trail Drive. The project also includes adding a crosswalk to the south side of the intersection. The traffic signal was slated to be operational before the end of November, and all pavement work and striping had been completed. Cochran’s Crossing Drive at Bay Branch Drive intersection

https://communityimpact.com/houston/the-woodlands/transportation/2020/11/27/two-new-traffic-signals-at-intersections-in-the-woodlands-slated-for-late-2020-operation/ [Training]

Russia says India to produce 100 million doses of Sputnik vaccine Apart from India, the RDIF says Sputnik V will also be produced in Brazil, China and South Korea. Russian President Vladimir Putin wearing protective gear walks at a hospital for patients infected with the coronavirus disease (COVID-19) on the outskirts of Moscow, Russia March 24, 2020 [Alexey Druzhinin/Kremlin/Sputnik via Reuters] One of the developers of Russia’s Sputnik V coronavirus vaccine announced on Friday that India-based drugmaker Hetero will produce more than 100 million doses of the jab. “Hetero, one of India’s leading generic pharmaceutical companies, have agreed to produce in India over 100 million doses per year of the world’s first registered vaccine against the novel coronavirus infection – Sputnik V,” the Russian Direct Investment Fund (RDIF) said in a statement, adding that production was expected to start in early 2021. Earlier this week, Russia said interim results from the Sputnik V clinical trials showed the vaccine was 95 percent effective, similar to other international vaccine makers that have also published test results showing efficacy rates of 90 percent and higher. Russia also announced the Sputnik V vaccine will be priced at $10 per dose on international markets, costing less than some other registered COVID-19 vaccines. Russia was the first country to announce the registration of a coronavirus vaccine in August – dubbed Sputnik V after the Soviet-era satellite – but did so ahead of large scale clinical trials. Currently, the third and final phase of trials is under way, with some 40,000 volunteers involved in blind testing of the vaccine that uses two different human adenovirus vectors. According to Friday’s statement, their use “allows for a stronger and longer-term immune response” compared with vaccines that use the same vector in both its doses. Third phase trials are also under way in the ex-Soviet republic of Belarus, the UAE and Venezuela among other countries. Apart from India, the RDIF says Sputnik V will also be produced in Brazil, China and South Korea.

https://www.aljazeera.com/news/2020/11/27/russia-says-india-to-produce-100-million-doses-of-sputnik-vaccine